Position in BMY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,180,115
+$701,526 QoQ
Shares Held
20,481
+159.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,075
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trivium Point Advisory, LLC holds $28,456,605 across 8 Drug Manufacturers - General names. BMY ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,340 | $16,000,397 | |
| 2 | JNJ |
Johnson & Johnson
|
12,027 | $3,054,497 | |
| 3 | ABBV |
AbbVie Inc.
|
10,728 | $2,699,593 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,671 | $2,270,723 | |
| 5 | AMGN |
Amgen Inc
|
3,478 | $1,259,453 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
20,481 | $1,180,115 | |
| 7 | PFE |
Pfizer Inc
|
45,408 | $1,093,424 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,111 | $898,403 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,180,115 | 20,481 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $478,589 | 7,891 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $581,257 | 10,776 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $386,236 | 8,564 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $512,569 | 11,073 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $688,028 | 11,281 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $553,835 | 9,792 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $408,383 | 7,893 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $302,047 | 7,273 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $333,460 | 6,149 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $238,899 | 4,656 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $285,150 | 4,913 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $316,616 | 4,951 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $362,491 | 5,230 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $379,032 | 5,268 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $377,203 | 5,306 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $429,814 | 5,582 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $541,809 | 7,419 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $493,687 | 7,918 | Shares | Sole | 2022-02-18 | |
| 2021-09-30 | $414,249 | 7,001 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,592,521 | 23,833 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,663,222 | 26,346 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,803,894 | 29,081 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,845,356 | 30,608 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,861,314 | 31,655 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $416,712 | 7,476 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||